Načítá se...
Alzheimer's disease drug development pipeline: 2018
INTRODUCTION: Treatments for Alzheimer's disease (AD) are needed due to the growing number of individuals with preclinical, prodromal, and dementia forms of AD. Drug development for AD therapies can be examined by inspecting the drug development pipeline as represented on clinicaltrials.gov. ME...
Uloženo v:
| Vydáno v: | Alzheimers Dement (N Y) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6021548/ https://ncbi.nlm.nih.gov/pubmed/29955663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2018.03.009 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|